Cargando…
Prognostic Biomarkers in Uveal Melanoma: The Status Quo, Recent Advances and Future Directions
SIMPLE SUMMARY: Although rare, uveal melanoma (UM) is the most common cancer that develops inside adult eyes. The prognosis is poor, since 50% of patients will develop lethal metastases in the first decade, especially to the liver. Once metastases are detected, life expectancy is limited, given that...
Autores principales: | Lamas, Nuno Jorge, Martel, Arnaud, Nahon-Estève, Sacha, Goffinet, Samantha, Macocco, Adam, Bertolotto, Corine, Lassalle, Sandra, Hofman, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749988/ https://www.ncbi.nlm.nih.gov/pubmed/35008260 http://dx.doi.org/10.3390/cancers14010096 |
Ejemplares similares
-
Assessment of Different Circulating Tumor Cell Platforms for Uveal Melanoma: Potential Impact for Future Routine Clinical Practice
por: Martel, Arnaud, et al.
Publicado: (2023) -
Recent advances in understanding the role of HES6 in cancers
por: Krossa, Imène, et al.
Publicado: (2022) -
Small but Challenging Conjunctival Melanoma: New Insights, Paradigms and Future Perspectives
por: Nahon-Estève, Sacha, et al.
Publicado: (2021) -
Liquid Biopsy for Solid Ophthalmic Malignancies: An Updated Review and Perspectives
por: Martel, Arnaud, et al.
Publicado: (2020) -
New Targeted Therapies and Immunotherapies for Locally Advanced Periocular Malignant Tumours: Towards a New ‘Eye-Sparing’ Paradigm?
por: Martel, Arnaud, et al.
Publicado: (2021)